欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/1253/001
药品名称Naproxen/Esomeprazole Sandoz 500/20 mg, modified release tablet
活性成分
    • Esomeprazole magnesium 20.0 mg
    • naproxen 500.0 mg
剂型Modified-release tablet
上市许可持有人Rowex Ltd, Newtown, Bantry, Co. Cork, Ireland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Austria (AT)
    • Spain (ES)
    • Portugal (PT)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      Esmapren 500 mg/20 mg modifikuoto atpalaidavimo tabletės
    • Estonia (EE)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2024/09/19
最近更新日期2024/09/19
药物ATC编码
    • M01AE52 naproxen and esomeprazole
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase